Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 657

1.

[A Case of Portal Vein Thrombosis Occurring during CapeOX and Bevacizumab Combination Therapy for Liver Metastasis].

Uno Y, Tsuboi K, Shimizu M, Tomosugi T, Shoka M, Hibino S, Matsushita H, Takahashi T, Okochi O, Kawase Y.

Gan To Kagaku Ryoho. 2016 Jul;43(7):905-7. Japanese.

PMID:
27431639
2.

Metabolic tumor volume on FDG-PET/CT is a possible prognostic factor for Stage I lung cancer patients treated with stereotactic body radiation therapy: a retrospective clinical study.

Takahashi N, Yamamoto T, Matsushita H, Sugawara T, Kubozono M, Umezawa R, Ishikawa Y, Kozumi M, Katagiri Y, Tasaka S, Takeda K, Takeda K, Dobashi S, Jingu K.

J Radiat Res. 2016 Jul 15. [Epub ahead of print]

3.

Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma.

Yamamoto T, Kadoya N, Takeda K, Matsushita H, Umezawa R, Sato K, Kubozono M, Ito K, Ishikawa Y, Kozumi M, Takahashi N, Katagiri Y, Onishi H, Jingu K.

Radiat Oncol. 2016 May 26;11(1):72. doi: 10.1186/s13014-016-0651-5.

4.

Evaluation of four-dimensional computed tomography (4D-CT)-based pulmonary ventilation: The high correlation between 4D-CT ventilation and (81m)Kr-planar images was found.

Kanai T, Kadoya N, Ito K, Kishi K, Dobashi S, Yamamoto T, Umezawa R, Matsushita H, Takeda K, Jingu K.

Radiother Oncol. 2016 Jun;119(3):444-8. doi: 10.1016/j.radonc.2016.04.030. Epub 2016 May 8.

PMID:
27165614
5.

Quantification of residual dose estimation error on log file-based patient dose calculation.

Katsuta Y, Kadoya N, Fujita Y, Shimizu E, Matsunaga K, Matsushita H, Majima K, Jingu K.

Phys Med. 2016 May;32(5):701-5. doi: 10.1016/j.ejmp.2016.04.015. Epub 2016 May 6.

PMID:
27162084
6.

Clinicopathologic Analysis of Angioimmunoblastic T-cell Lymphoma With or Without RHOA G17V Mutation Using Formalin-fixed Paraffin-embedded Sections.

Nagao R, Kikuti YY, Carreras J, Kikuchi T, Miyaoka M, Matsushita H, Kojima M, Ando K, Sakata-Yanagimoto M, Chiba S, Nakamura N.

Am J Surg Pathol. 2016 Aug;40(8):1041-50. doi: 10.1097/PAS.0000000000000651.

PMID:
27158755
7.

Assessment of epigenetic alterations in early colorectal lesions containing BRAF mutations.

Sawada T, Yamamoto E, Yamano HO, Nojima M, Harada T, Maruyama R, Ashida M, Aoki H, Matsushita HO, Yoshikawa K, Harada E, Tanaka Y, Wakita S, Niinuma T, Kai M, Eizuka M, Sugai T, Suzuki H.

Oncotarget. 2016 Apr 27. doi: 10.18632/oncotarget.9044. [Epub ahead of print]

8.

The formation of an aberrant PAX5 transcript in a patient with mixed phenotype acute leukemia harboring der(9)t(7;9)(q11.2;p13).

Amaki J, Matsushita H, Kitamura Y, Nagao R, Murayama H, Kojima M, Ando K.

Leuk Res Rep. 2016 Apr 12;5:14-7. doi: 10.1016/j.lrr.2016.04.001. eCollection 2016.

9.

Refractory acute promyelocytic leukemia successfully treated with combination therapy of arsenic trioxide and tamibarotene: A case report.

Kojima M, Ogiya D, Ichiki A, Hara R, Amaki J, Kawai H, Numata H, Sato A, Miyamoto M, Suzuki R, Machida S, Matsushita H, Ogawa Y, Kawada H, Ando K.

Leuk Res Rep. 2016 Jan 22;5:11-3. doi: 10.1016/j.lrr.2016.01.001. eCollection 2016.

10.

Meigs Syndrome Superimposed on Gorlin Syndrome in a 14-Year-Old Girl.

Iwasaki K, Matsushita H, Murakami H, Watanabe K, Wakatsuki A.

J Pediatr Adolesc Gynecol. 2016 Apr 11. pii: S1083-3188(16)30007-9. doi: 10.1016/j.jpag.2016.03.010. [Epub ahead of print]

PMID:
27079916
11.

High event-free survival rate with minimum-dose-anthracycline treatment in childhood acute promyelocytic leukaemia: a nationwide prospective study by the Japanese Paediatric Leukaemia/Lymphoma Study Group.

Takahashi H, Watanabe T, Kinoshita A, Yuza Y, Moritake H, Terui K, Iwamoto S, Nakayama H, Shimada A, Kudo K, Taki T, Yabe M, Matsushita H, Yamashita Y, Koike K, Ogawa A, Kosaka Y, Tomizawa D, Taga T, Saito AM, Horibe K, Nakahata T, Miyachi H, Tawa A, Adachi S.

Br J Haematol. 2016 Aug;174(3):437-43. doi: 10.1111/bjh.14068. Epub 2016 Mar 31.

PMID:
27029412
12.

Oxidative stress balance is dysregulated and represents an additional target for treating cholangiocarcinoma.

Uchida D, Takaki A, Ishikawa H, Tomono Y, Kato H, Tsutsumi K, Tamaki N, Maruyama T, Tomofuji T, Tsuzaki R, Yasunaka T, Koike K, Matsushita H, Ikeda F, Miyake Y, Shiraha H, Nouso K, Yoshida R, Umeda Y, Shinoura S, Yagi T, Fujiwara T, Morita M, Fukushima M, Yamamoto K, Okada H.

Free Radic Res. 2016 Jul;50(7):732-43. doi: 10.3109/10715762.2016.1172071. Epub 2016 Apr 25.

PMID:
27021847
13.

Advances in personalized cancer immunotherapy.

Kakimi K, Karasaki T, Matsushita H, Sugie T.

Breast Cancer. 2016 Mar 21. [Epub ahead of print]

PMID:
27000871
14.

MAGE-A expression, immune microenvironment, and prognosis in upper urinary tract carcinoma.

Makise N, Morikawa T, Nakagawa T, Ichimura T, Kawai T, Matsushita H, Kakimi K, Kume H, Homma Y, Fukayama M.

Hum Pathol. 2016 Apr;50:62-9. doi: 10.1016/j.humpath.2015.11.007. Epub 2015 Nov 28.

PMID:
26997439
15.

Neoantigen Load, Antigen Presentation Machinery, and Immune Signatures Determine Prognosis in Clear Cell Renal Cell Carcinoma.

Matsushita H, Sato Y, Karasaki T, Nakagawa T, Kume H, Ogawa S, Homma Y, Kakimi K.

Cancer Immunol Res. 2016 May;4(5):463-71. doi: 10.1158/2326-6066.CIR-15-0225. Epub 2016 Mar 15.

PMID:
26980598
16.

Exosome Migration Inhibitory Factor as a Marker and Therapeutic Target for Pancreatic Cancer.

Matsushita H, Yang YM, Pandol SJ, Seki E.

Gastroenterology. 2016 Apr;150(4):1033-5. doi: 10.1053/j.gastro.2016.02.051. Epub 2016 Feb 27. No abstract available.

17.

Comparison of visual biofeedback system with a guiding waveform and abdomen-chest motion self-control system for respiratory motion management.

Nakajima Y, Kadoya N, Kanai T, Ito K, Sato K, Dobashi S, Yamamoto T, Ishikawa Y, Matsushita H, Takeda K, Jingu K.

J Radiat Res. 2016 Feb 27. pii: rrv106. [Epub ahead of print]

18.

Hepatic Effects of Estrogen on Plasma Distribution of Small Dense Low-Density Lipoprotein and Free Radical Production in Postmenopausal Women.

Nii S, Shinohara K, Matsushita H, Noguchi Y, Watanabe K, Wakatsuki A.

J Atheroscler Thromb. 2016 Jul 1;23(7):810-8. doi: 10.5551/jat.33175. Epub 2016 Feb 22.

19.

Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo.

Luke T, Wu H, Zhao J, Channappanavar R, Coleman CM, Jiao JA, Matsushita H, Liu Y, Postnikova EN, Ork BL, Glenn G, Flyer D, Defang G, Raviprakash K, Kochel T, Wang J, Nie W, Smith G, Hensley LE, Olinger GG, Kuhn JH, Holbrook MR, Johnson RF, Perlman S, Sullivan E, Frieman MB.

Sci Transl Med. 2016 Feb 17;8(326):326ra21. doi: 10.1126/scitranslmed.aaf1061.

PMID:
26888429
20.

Four hepatosplenic T-cell lymphoma cases of Japanese patients.

Kawai H, Matsushita H, Ohmachi K, Kojima M, Machida S, Ogawa Y, Kawada H, Nakamura N, Ando K.

Leuk Res Rep. 2015 Dec 15;5:3-6. doi: 10.1016/j.lrr.2015.12.001. eCollection 2016.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk